These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 2766027)

  • 1. Prevalence of genotoxic chemicals among animal and human carcinogens evaluated in the IARC Monograph Series.
    Bartsch H; Malaveille C
    Cell Biol Toxicol; 1989 Jun; 5(2):115-27. PubMed ID: 2766027
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The relation between carcinogenesis and mutagenesis: a re-evaluation].
    Bartsch H; Malaveille C
    Bull Acad Natl Med; 1989 Nov; 173(8):1005-12; discussion 1013-5. PubMed ID: 2633853
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Screening assays for carcinogenic agents and mixtures: an appraisal based on data in the IARC Monograph series.
    Bartsch H; Malaveille C
    IARC Sci Publ; 1990; (104):65-74. PubMed ID: 2228144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Genotoxicity of carcinogenic substances in humans and animals].
    Malaveille C; Bartsch H
    J Toxicol Clin Exp; 1989; 9(2 Pt 2):15-25. PubMed ID: 2677321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The comet assay with multiple mouse organs: comparison of comet assay results and carcinogenicity with 208 chemicals selected from the IARC monographs and U.S. NTP Carcinogenicity Database.
    Sasaki YF; Sekihashi K; Izumiyama F; Nishidate E; Saga A; Ishida K; Tsuda S
    Crit Rev Toxicol; 2000 Nov; 30(6):629-799. PubMed ID: 11145306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mouse-specific carcinogens: an assessment of hazard and significance for validation of short-term carcinogenicity bioassays in transgenic mice.
    Battershill JM; Fielder RJ
    Hum Exp Toxicol; 1998 Apr; 17(4):193-205. PubMed ID: 9617631
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The alkaline single cell gel electrophoresis assay with mouse multiple organs: results with 30 aromatic amines evaluated by the IARC and U.S. NTP.
    Sasaki YF; Fujikawa K; Ishida K; Kawamura N; Nishikawa Y; Ohta S; Satoh M; Madarame H; Ueno S; Susa N; Matsusaka N; Tsuda S
    Mutat Res; 1999 Mar; 440(1):1-18. PubMed ID: 10095124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the ability of a battery of three in vitro genotoxicity tests to discriminate rodent carcinogens and non-carcinogens I. Sensitivity, specificity and relative predictivity.
    Kirkland D; Aardema M; Henderson L; Müller L
    Mutat Res; 2005 Jul; 584(1-2):1-256. PubMed ID: 15979392
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic toxicology data in the evaluation of potential human environmental carcinogens.
    Waters MD; Stack HF; Jackson MA
    Mutat Res; 1999 Jul; 437(1):21-49. PubMed ID: 10425388
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison between carcinogenicity and mutagenicity based on chemicals evaluated in the IARC monographs.
    Bartsch H; Tomatis L
    Environ Health Perspect; 1983 Jan; 47():305-17. PubMed ID: 6337827
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The results of assays in Drosophila as indicators of exposure to carcinogens.
    Vogel EW; Graf U; Frei HJ; Nivard MM
    IARC Sci Publ; 1999; (146):427-70. PubMed ID: 10353398
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The prospects for a simplified and internationally harmonized approach to the detection of possible human carcinogens and mutagens.
    Ashby J
    Mutagenesis; 1986 Jan; 1(1):3-16. PubMed ID: 3325732
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heritable and cancer risks of exposures to anticancer drugs: inter-species comparisons of covalent deoxyribonucleic acid-binding agents.
    Vogel EW; Barbin A; Nivard MJ; Stack HF; Waters MD; Lohman PH
    Mutat Res; 1998 May; 400(1-2):509-40. PubMed ID: 9685708
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An integrated in vitro carcinogenicity test that distinguishes between genotoxic carcinogens, non-genotoxic carcinogens, and non-carcinogens.
    Chapman KE; Shah UK; Fletcher JF; Johnson GE; Doak SH; Jenkins GJS
    Mutagenesis; 2024 Mar; 39(2):69-77. PubMed ID: 38301659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Short-term tests for defining mutagenic carcinogens.
    Waters MD; Stack HF; Jackson MA
    IARC Sci Publ; 1999; (146):499-536. PubMed ID: 10353401
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Guidelines for the evaluation of chemicals for carcinogenicity. Committee on Carcinogenicity of Chemicals in Food, Consumer Products and the Environment.
    Rep Health Soc Subj (Lond); 1991; 42():1-80. PubMed ID: 1763238
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An integrative test strategy for cancer hazard identification.
    Luijten M; Olthof ED; Hakkert BC; Rorije E; van der Laan JW; Woutersen RA; van Benthem J
    Crit Rev Toxicol; 2016 Aug; 46(7):615-39. PubMed ID: 27142259
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Failure of the standard battery of short-term tests in detecting some rodent and human genotoxic carcinogens.
    Brambilla G; Martelli A
    Toxicology; 2004 Mar; 196(1-2):1-19. PubMed ID: 15036752
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carcinogenicity categorization of chemicals-new aspects to be considered in a European perspective.
    Bolt HM; Foth H; Hengstler JG; Degen GH
    Toxicol Lett; 2004 Jun; 151(1):29-41. PubMed ID: 15177638
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms of non-genotoxic carcinogens and importance of a weight of evidence approach.
    Hernández LG; van Steeg H; Luijten M; van Benthem J
    Mutat Res; 2009; 682(2-3):94-109. PubMed ID: 19631282
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.